Progresses and Perspectives of Anti-PD-1/PD-L1 Antibody Therapy in Head and Neck Cancers
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference123 articles.
1. Epidemiology, staging, and screening of head and neck cancer;Argiris;Cancer Treat Res,2003
2. Head and neck cancer;Argiris;Lancet,2008
3. T cell-tumor interaction directs the development of immunotherapies in head and neck cancer;Albers;Clin Dev Immunol,2010
4. Tobacco and cancer: recent epidemiological evidence;Vineis;J Natl Cancer Inst,2004
5. Smoking and drinking in relation to oral and pharyngeal cancer;Blot;Cancer Res,1988
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Engineering Microorganisms for Cancer Immunotherapy;Advanced Healthcare Materials;2024-04-21
2. Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy;Advanced Materials;2024-03-04
3. Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance;International Journal of Nanomedicine;2024-02
4. Integrative analysis of the cuproptosis-related gene ATP7B in the prognosis and immune infiltration of IDH1 wild-type glioma;Gene;2024-01
5. Progresses in biomarkers for cancer immunotherapy;MedComm;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3